The Effect of SOCS2 Polymorphisms on Type 2 Diabetes Mellitus Susceptibility and Diabetic Complications in the Chinese Han Population

References

• Vijan S. Type 2 diabetes. Ann Intern Med. 2019;171(9):Itc65–itc80. doi:10.7326/AITC201911050
   PubMed Web of Science ®Google Scholar
• Cho NH, Shaw JE, Karuranga S, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–281. doi:10.1016/j.diabres.2018.02.023
   PubMed Web of Science ®Google Scholar
• Jia W, Weng J, Zhu D, et al. Standards of medical care for type 2 diabetes in China 2019. Diabetes Metab Res Rev. 2019;35(6):e3158.
   PubMed Web of Science ®Google Scholar
• Ma RCW. Epidemiology of diabetes and diabetic complications in China. Diabetologia. 2018;61(6):1249–1260. doi:10.1007/s00125-018-4557-7
   PubMed Web of Science ®Google Scholar
• Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98. doi:10.1038/nrendo.2017.151
   PubMed Web of Science ®Google Scholar
• Xue A, Wu Y. Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes. Nat Commun. 2018;9(1):2941. doi:10.1038/s41467-018-04951-w
   PubMed Web of Science ®Google Scholar
• Mir R, Elfaki I, Duhier FMA, Alotaibi MA. Molecular determination of mirRNA-126 rs4636297, phosphoinositide-3-kinase regulatory subunit 1-gene variability rs7713645, rs706713 (Tyr73Tyr), rs3730089 (Met326Ile) and their association with susceptibility to T2D. J Pers Med. 2021;11(9):861. doi:10.3390/jpm11090861
   PubMed Web of Science ®Google Scholar
• Ding Q, Tan ALM, Parra EJ, Cruz M, Sim X. Genome-wide meta-analysis associates GPSM1 with type 2 diabetes, a plausible gene involved in skeletal muscle function. J Hum Genet. 2020;65(4):411–420. doi:10.1038/s10038-019-0720-3
   PubMed Web of Science ®Google Scholar
• Mattis KK, Gloyn AL. From genetic association to molecular mechanisms for islet-cell dysfunction in type 2 diabetes. J Mol Biol. 2020;432(5):1551–1578. doi:10.1016/j.jmb.2019.12.045
   PubMed Web of Science ®Google Scholar
• Hebbar P, Abu-Farha M, Melhem M, et al. Genome-wide association study identifies novel risk variants from RPS6KA1, CADPS, VARS, and DHX58 for fasting plasma glucose in Arab population. Sci Rep. 2020;10(1):152. doi:10.1038/s41598-019-57072-9
   PubMed Web of Science ®Google Scholar
• Inagaki-Ohara K, Kondo T, Ito M, Yoshimura A. SOCS, inflammation, and cancer. Jak-Stat. 2013;2(3):e24053. doi:10.4161/jkst.24053
   PubMedGoogle Scholar
• Letellier E, Haan S. SOCS2: physiological and pathological functions. Front Biosci. 2016;8:189–204. doi:10.2741/E760
   Google Scholar
• Zhou Y, Zhang Z, Wang N, et al. Suppressor of cytokine signalling-2 limits IGF1R-mediated regulation of epithelial-mesenchymal transition in lung adenocarcinoma. Cell Death Dis. 2018;9(4):429. doi:10.1038/s41419-018-0457-5
   PubMed Web of Science ®Google Scholar
• Isshiki K, He Z, Maeno Y, et al. Insulin regulates SOCS2 expression and the mitogenic effect of IGF-1 in mesangial cells. Kidney Int. 2008;74(11):1434–1443. doi:10.1038/ki.2008.403
   PubMed Web of Science ®Google Scholar
• Lebrun P, Cognard E, Gontard P, et al. The suppressor of cytokine signalling 2 (SOCS2) is a key repressor of insulin secretion. Diabetologia. 2010;53(9):1935–1946. doi:10.1007/s00125-010-1786-9
   PubMed Web of Science ®Google Scholar
• Bao NN, Kong DY, Zhu D, Hao LR. Influence of overexpression of SOCS2 on cells of DN rat. Asian Pac J Trop Med. 2015;8(7):583–589. doi:10.1016/j.apjtm.2015.06.006
   PubMed Web of Science ®Google Scholar
• Gao J, Wei L, Liu X, et al. Association between IFN-gamma gene polymorphisms and IgA nephropathy in a Chinese han population. Kidney Blood Press Res. 2017;42(1):136–144. doi:10.1159/000473889
   PubMed Web of Science ®Google Scholar
• van Dijk EL, Jaszczyszyn Y, Naquin D, Thermes C. The third revolution in sequencing technology. Trends Genet. 2018;34(9):666–681. doi:10.1016/j.tig.2018.05.008
   PubMed Web of Science ®Google Scholar
• Yang P, Wang M, Tian T, et al. CYP17 polymorphisms are associated with decreased risk of breast cancer in Chinese Han women: a case-control study. Cancer Manag Res. 2018;10:1791–1798. doi:10.2147/CMAR.S167503
   PubMed Web of Science ®Google Scholar
• Trarbach EB, Jorge AA, Duarte FH, Bronstein MD, Jallad RS. SOCS2 polymorphisms are not associated with clinical and biochemical phenotypes in acromegalic patients. Pituitary. 2017;20(3):319–324. doi:10.1007/s11102-016-0779-1
   PubMed Web of Science ®Google Scholar
• Glad CA, Barbosa EJ, Filipsson Nystrom H, et al. SNPs within the GH-signaling pathway are associated with the early IGF1 response to GH replacement therapy in GHD adults. Eur J Endocrinol. 2014;170(1):101–107. doi:10.1530/EJE-13-0685
   PubMed Web of Science ®Google Scholar
• DiStefano JK, Kingsley C, Craig Wood G, et al. Genome-wide analysis of hepatic lipid content in extreme obesity. Acta Diabetol. 2015;52(2):373–382. doi:10.1007/s00592-014-0654-3
   PubMed Web of Science ®Google Scholar
• Rasche A, Al-Hasani H, Herwig R. Meta-analysis approach identifies candidate genes and associated molecular networks for type-2 diabetes mellitus. BMC genomics. 2008;9(1):310. doi:10.1186/1471-2164-9-310
   PubMed Web of Science ®Google Scholar
• Feng X, Tang H, Leng J, Jiang Q. Suppressors of cytokine signaling (SOCS) and type 2 diabetes. Mol Biol Rep. 2014;41(4):2265–2274. doi:10.1007/s11033-014-3079-8
   PubMed Web of Science ®Google Scholar
• Kato H, Nomura K, Osabe D, et al. Association of single-nucleotide polymorphisms in the suppressor of cytokine signaling 2 (SOCS2) gene with type 2 diabetes in the Japanese. Genomics. 2006;87(4):446–458. doi:10.1016/j.ygeno.2005.11.009
   PubMed Web of Science ®Google Scholar
• Zhang N, Du SM, Ma GS. Current lifestyle factors that increase risk of T2DM in China. Eur J Clin Nutr. 2017;71(7):832–838. doi:10.1038/ejcn.2017.41
   PubMed Web of Science ®Google Scholar
• Davila-Cervantes CA, Agudelo-Botero M. Sex disparities in the epidemic of type 2 diabetes in Mexico: national and state level results based on the Global Burden of Disease Study, 1990–2017. Diabetes Metab Syndr Obes. 2019;12:1023–1033. doi:10.2147/DMSO.S205198
   PubMed Web of Science ®Google Scholar
• Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016;37(3):278–316. doi:10.1210/er.2015-1137
   PubMed Web of Science ®Google Scholar
• Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2007;298(22):2654–2664. doi:10.1001/jama.298.22.2654
   PubMed Web of Science ®Google Scholar
• Baliunas DO, Taylor BJ, Irving H, et al. Alcohol as a risk factor for type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2009;32(11):2123–2132. doi:10.2337/dc09-0227
   PubMed Web of Science ®Google Scholar
• Estampador AC, Franks PW. Precision medicine in obesity and type 2 diabetes: the relevance of early-life exposures. Clin Chem. 2018;64(1):130–141. doi:10.1373/clinchem.2017.273540
   PubMed Web of Science ®Google Scholar
• Ingelsson E, McCarthy MI. Human genetics of obesity and type 2 diabetes mellitus: past, present, and future. Circ Genom Precis Med. 2018;11(6):e002090. doi:10.1161/CIRCGEN.118.002090
   PubMed Web of Science ®Google Scholar
• Pinhas-Hamiel O, Zeitler P. Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet. 2007;369(9575):1823–1831. doi:10.1016/S0140-6736(07)60821-6
   PubMed Web of Science ®Google Scholar
• Naito R. Miyauchi K: coronary artery disease and type 2 diabetes mellitus. Int Heart J. 2017;58(4):475–480. doi:10.1536/ihj.17-191
   PubMed Web of Science ®Google Scholar
• Pavlou DI, Paschou SA, Anagnostis P, et al. Hypertension in patients with type 2 diabetes mellitus: targets and management. Maturitas. 2018;112:71–77. doi:10.1016/j.maturitas.2018.03.013
   PubMed Web of Science ®Google Scholar
• Yang S, Zhang J, Wang S, Zhao X, Shi J. SOCS2 overexpression alleviates diabetic nephropathy in rats by inhibiting the TLR4/NF-κB pathway. Oncotarget. 2017;8(53):91185–91198. doi:10.18632/oncotarget.20434
   PubMedGoogle Scholar
• Xue X, Luo L. LncRNA HIF1A-AS1 contributes to ventricular remodeling after myocardial ischemia/reperfusion injury by adsorption of microRNA-204 to regulating SOCS2 expression. Cell Cycle. 2019;18(19):2465–2480. doi:10.1080/15384101.2019.1648960
   PubMed Web of Science ®Google Scholar
• Pan J, Tong R, Deng Q, et al. The Effect of SOCS2 Polymorphisms on Type 2 Diabetes Mellitus Susceptibility and Diabetic Complications in the Chinese Han Population. 2020; Preprint. Available from: https://www.researchsquare.com/article/rs-39248/v1. Accessed January 6, 2022.
   Google Scholar